Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 15, 2018

Primary Completion Date

October 2, 2020

Study Completion Date

October 2, 2020

Conditions

Atherosclerosis, Coronary

Interventions

DRUG

Autologous CD34+ Cells

The dose will be 1x10\^5 cells/kg, injected at the rate of 10 ml/min

DRUG

Granulocyte Colony-Stimulating Factor (G-CSF)

5mg/kg twice daily

Trial Locations (1)

Mayo Clinic in Rochester, Rochester